As of May 26
| 0.00 / 0.00%|
The 15 analysts offering 12-month price forecasts for Imperva Inc have a median target of 53.00, with a high estimate of 57.00 and a low estimate of 37.00. The median estimate represents a +4.54% increase from the last price of 50.70.
The current consensus among 18 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.